Sage Rhino Capital LLC Johnson & Johnson Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sage Rhino Capital LLC holds 6,881 shares of JNJ stock, worth $1.07 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

6,881

Previous 6,988 1.53%

Holding current value

$1.07 Million

Previous $1.02 Million 9.21%

% of portfolio

0.25%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$145.48 - $167.38 $15,566 - $17,909	-107 Reduced 1.53%	6,881 $1.12 Million
Q2 2024 Jul 30, 2024	SELL	$144.38 - $157.78 $6,785 - $7,415	-47 Reduced 0.67%	6,988 $1.02 Million
Q1 2024 Apr 26, 2024	BUY	$155.22 - $162.74 $14,745 - $15,460	95 Added 1.37%	7,035 $1.11 Million
Q4 2023 Feb 05, 2024	SELL	$145.6 - $158.88 $3,348 - $3,654	-23 Reduced 0.33%	6,940 $1.09 Million
Q3 2023 Oct 26, 2023	SELL	$155.75 - $174.48 $4,205 - $4,710	-27 Reduced 0.39%	6,963 $1.08 Million
Q2 2023 Jul 31, 2023	BUY	$154.35 - $166.11 $2,006 - $2,159	13 Added 0.19%	6,990 $1.16 Million
Q1 2023 Apr 20, 2023	SELL	$151.05 - $180.26 $33,079 - $39,476	-219 Reduced 3.04%	6,977 $1.08 Million
Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $7,369 - $8,270	46 Added 0.64%	7,196 $1.27 Million
Q3 2022 Oct 24, 2022	SELL	$161.33 - $179.52 $13,713 - $15,259	-85 Reduced 1.17%	7,150 $1.17 Million
Q2 2022 Jul 28, 2022	BUY	$168.19 - $186.01 $6,054 - $6,696	36 Added 0.5%	7,235 $1.28 Million
Q1 2022 Apr 27, 2022	BUY	$158.14 - $179.59 $2,530 - $2,873	16 Added 0.22%	7,199 $1.28 Million
Q4 2021 Feb 04, 2022	BUY	$155.93 - $173.01 $24,169 - $26,816	155 Added 2.21%	7,183 $1.23 Million
Q3 2021 Oct 18, 2021	BUY	$161.5 - $179.47 $2,584 - $2,871	16 Added 0.23%	7,028 $1.14 Million
Q2 2021 Jul 27, 2021	BUY	$159.48 - $171.07 $16,107 - $17,278	101 Added 1.46%	7,012 $1.16 Million
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $33,063 - $36,823	216 Added 3.23%	6,911 $1.14 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $9,871 - $11,331	72 Added 1.09%	6,695 $1.05 Million
Q3 2020 Nov 05, 2020	BUY	$140.38 - $153.83 $561 - $615	4 Added 0.06%	6,623 $986,000
Q2 2020 Jul 30, 2020	BUY	$128.81 - $155.51 $17,904 - $21,615	139 Added 2.15%	6,619 $931,000
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $13,447 - $18,632	121 Added 1.9%	6,480 $850,000
Q4 2019 Jan 31, 2020	BUY	$127.5 - $146.44 $6,757 - $7,761	53 Added 0.84%	6,359 $922,000
Q3 2019 Oct 25, 2019	BUY	$126.95 - $142.14 $507 - $568	4 Added 0.06%	6,306 $816,000
Q2 2019 Aug 20, 2019	BUY	$131.15 - $144.24 $9,705 - $10,673	74 Added 1.19%	6,302 $878,000
Q1 2019 Apr 18, 2019	BUY	$125.72 - $139.79 $782,984 - $870,612	6,228 New	6,228 $871,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Johnson & Johnson Transaction History